trending Market Intelligence /marketintelligence/en/news-insights/trending/_gi9mp8hnldw5trgcow5rw2 content esgSubNav
In This List

Tetraphase Pharmaceuticals CFO resigns

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Tetraphase Pharmaceuticals CFO resigns

Tetraphase Pharmaceuticals Inc. said Kamalam Unninayar resigned as CFO on March 16.

Unninayar joined the Watertown, Mass.-based antibiotics developer in October 2017.

Senior Vice President of Finance Christopher Watt will act as principal financial officer and principal accounting officer until a replacement CFO is named, Tetraphase said in a filing.